세계의 맘모그래피 시장 규모, 점유율, 동향 분석 : 제품별, 기술별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Mammography Market Size, Share & Trends Analysis Report By Product, By Technology, By End Use, By Region And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,515,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,946,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,809,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

맘모그래피 시장의 성장과 동향 :

세계의 맘모그래피 시장 규모는 2030년까지 46억 7,000만 달러에 달할 것으로 예측되며, 2025-2030년의 CAGR은 10.50%로 성장할 것으로 예측됩니다.

이러한 성장의 주요 요인은 유방 조직 미세석회화 조기 진단에 대한 인식을 높이기 위한 다양한 정부 및 NGO의 노력이 활발히 진행되고 있기 때문입니다.

예를 들어 네덜란드의 National Breast Cancer Screening Programme은 50세에서 75세 사이의 여성을 대상으로 설립되었습니다. 이 프로그램에 따르면 이 연령대의 여성들은 2년마다 유방촬영을 받도록 권유받았습니다. 마찬가지로 호주에서는 정부의 국가 검진 프로그램인 Breast Screen Australia의 일환으로 50세에서 74세 사이의 여성은 2년마다 무료로 유방촬영을 받도록 의무화되어 있습니다. 미국 유방암 재단, CDC, Breast Cancer Organization과 같은 다른 중요한 조직들도 유방 석회화의 조기 진단을 장려하고 있습니다. 이는 시장 성장을 가속할 것으로 예상되는 중요한 요인 중 하나입니다.

주요 유방 조영술 제조업체들은 신제품을 출시하고 승인된 제품 수를 늘리고 있으며, 이는 향후 수년간 수요를 더욱 촉진할 것으로 예상됩니다. 예를 들어 2018년 3월 지멘스 헬시니어스(Siemens Healthineers)는 강화된 유방촬영 플랫폼인 MAMMOMAT Revelation에 대한 미국 FDA 승인을 획득했습니다. 이 플랫폼은 새로운 검체 이미징 툴인 Inspect와 한 번의 클릭으로 환부를 겨냥할 수 있는 새로운 HD Breast Biopsy 기술과 결합되어 있습니다. 또한 2021년 10월, iCAD는 차세대 2D 유방촬영용 ProFound AI를 출시했습니다.

또한 3D 유방촬영술에 인공지능(AI)을 활용하면 이미지 품질은 유지하면서 검사 시간을 단축할 수 있습니다. 예를 들어 2021년 3월 iCad는 디지털 유방 조영술(DBT) 시스템용 ProFound AI 버전 3.0의 미국 식품의약국(USFDA) 승인을 획득했습니다. 이전 버전에 비해 특이도 성능이 최대 10% 향상되었고, 민감도가 최대 1% 향상되었으며, 처리 속도가 40% 빨라졌습니다. 이처럼 AI 지원 3D 맘모그래피 장비의 FDA 승인이 빠르게 진행되고 있는 것이 시장 성장의 원동력이 되고 있습니다.

유방 조영술 시장 보고서 하이라이트

• 디지털 시스템 부문은 2024년 59.82% 이상의 매출 점유율로 시장을 독점하며, 예측 기간 중 상당한 성장이 예상됩니다.
• 디지털 유방 조영술 기술 부문은 이 기술의 다양한 장점으로 인해 2024년 65.94% 이상의 가장 큰 매출 점유율을 차지했습니다.
• 병원 최종 사용 부문은 2024년 약 45.68%의 매출 점유율로 시장을 장악했습니다.
• 북미 유방촬영술 시장은 2024년 세계 매출에서 35.48%의 가장 큰 점유율을 차지했습니다. 이 지역의 유방암 발병률 증가가 시장 성장을 이끄는 주요 요인 중 하나입니다.

목차

제1장 분석 방법·범위

제2장 개요

제3장 맘모그래피 시장 : 변동 요인·동향·범위

• 시장 연관 전망
  • 모시장 전망
  • 관련/부수 시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 맘모그래피 시장 : 분석 툴
  • 업계 분석 : Porter의 산업 분석
  • PESTEL 분석

제4장 맘모그래피 시장 : 제품별 추정·동향 분석

• 부문 대시보드
• 맘모그래피 시장 : 변동 분석, 제품별(2024년·2030년)
• 세계의 맘모그래피 시장 규모와 동향 분석 : 제품별(2018-2030년)
• 필름 스크린 시스템
• 디지털 시스템
• 아날로그 시스템
• 3D 시스템

제5장 맘모그래피 시장 : 기술별 추정·동향 분석

• 부문 대시보드
• 맘모그래피 시장 : 변동 분석, 기술별(2024년·2030년)
• 세계의 맘모그래피 시장 규모와 동향 분석 : 기술별(2018-2030년)
• 유방 토모신테시스
• CAD
• 디지털

제6장 맘모그래피 시장 : 최종 용도별 추정·동향 분석

• 부문 대시보드
• 맘모그래피 시장 : 변동 분석, 최종 용도별(2024년·2030년)
• 세계의 맘모그래피 시장 규모와 동향 분석 : 최종 용도별(2018-2030년)
• 병원
• 전문 클리닉
• 진단 센터
• 기타

제7장 맘모그래피 시장 : 지역별 추정·동향 분석(제품별·기술별·최종 용도별)

• 지역 대시보드
• 시장 규모와 동향 분석(2018-2030년)
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 스웨덴
  • 덴마크
  • 노르웨이
• 아시아태평양
  • 중국
  • 일본
  • 인도
  • 한국
  • 호주
  • 태국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 사우디아라비아
  • 아랍에미리트
  • 남아프리카공화국
  • 쿠웨이트

제8장 경쟁 구도

• 최근 동향과 영향 분석 : 주요 시장 참여 기업별
• 기업 분류
• 기업의 시장 점유율 분석
• 기업 히트맵 분석
• 전략 지도제작
  • 확대
  • 기업인수합병(M&A)
  • 파트너십과 협업
  • 신제품의 발매
  • 연구개발
  • 기업 개요
  • Hologic Inc.
  • Analogic Corporation
  • Canon Medical Systems Corporation
  • Fujifilm Corporation
  • Siemens Healthcare
  • Toshiba Medical Systems
  • GE Healthcare
  • Metaltronica
  • Koninklijke Philips NV
  • PLANMED OY

KSA

영문 목차

영문목차

Mammography Market Growth & Trends:

The global mammography market size is expected to reach USD 4.67 billion by 2030 and is projected to grow at a CAGR of 10.50% from 2025 to 2030. The growth is mainly driven by the rising initiatives by various governments and NGOs to raise awareness about the early diagnosis of microcalcifications in breast tissue.

For instance, the National Breast Cancer Screening Programme in the Netherlands, for example, was created for women aged 50 to 75. According to the program, women in this age bracket were invited for a mammogram every two years. Similarly, in Australia, women aged 50 to 74 are required to have free mammograms every 2 years as part of the government's national screening program, Breast Screen Australia. Some other significant organizations such as the National Breast Cancer Foundation, CDC, and Breast Cancer Organization are promoting early diagnosis of mammary gland calcification. This is one of the crucial factors expected to drive market growth.

Major mammography manufacturers are introducing new products and increasing the number of approved products, which is further expected to impel the demand in the coming years. For instance, in March 2018, Siemens Healthineers obtained U.S. FDA approval for its enhanced mammography platform MAMMOMAT Revelation. This platform is combined with a new InSpect specimen imaging tool as well as new HD Breast Biopsy technology for one-click targeting of affected areas. Moreover, in October 2021, iCAD, Inc. launched its latest generation of ProFound AI for 2D Mammography.

Furthermore, the use of Artificial Intelligence (AI) in 3D mammography has reduced exam time while maintaining image quality. For instance, in March 2021, iCad received USFDA approval for its ProFound AI Version 3.0 for Digital Breast Tomosynthesis (DBT) system. Compared to previous versions of the software, it provides up to a 10% enhancement in specificity performance, up to 1% improvement in sensitivity, and offers 40% faster processing. Thus, rapid FDA approval for AI-enabled 3D mammography equipment is driving market growth.

Mammography Market Report Highlights:

• The digital systems segment dominated the market with a revenue share of more than 59.82% in 2024 and is expected to witness considerable growth over the forecast period.
• The digital mammography technology segment accounted for the largest revenue share of more than 65.94% in 2024 due to the various advantages of this technology.
• The hospitals end Use segment dominated the market in 2024 with a revenue share of around 45.68%.
• The mammography market in North America held the largest share of 35.48% of the global revenue in 2024. The rising incidence of breast cancer in the region is one of the major factors driving the market growth.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
• 1.5. Details of primary research
  • 1.5.1. Data for primary interviews in North America
  • 1.5.2. Data for primary interviews in Europe
  • 1.5.3. Data for primary interviews in Asia Pacific
  • 1.5.4. Data for primary interviews in Latin America
  • 1.5.5. Data for Primary interviews in MEA
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.1.1. Approach 1: Commodity flow approach
  • 1.7.2. Volume price analysis (Model 2)
    • 1.7.2.1. Approach 2: Volume price analysis
• 1.8. Research Scope and Assumptions
  • 1.8.1. List of Secondary Sources
  • 1.8.2. List of Primary Sources
  • 1.8.3. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Mammography Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Drivers Analysis
    • 3.2.1.1. Rising prevalence of breast cancer
    • 3.2.1.2. Favorable government initiatives
    • 3.2.1.3. Introduction of innovative technology-based products
  • 3.2.2. Market Restraints Analysis
    • 3.2.2.1. Introduction of innovative technology-based products
    • 3.2.2.2. Stringent manufacturing policies
• 3.3. Mammography Market Analysis Tools
  • 3.3.1. Porter's Analysis
    • 3.3.1.1. Bargaining power of the suppliers
    • 3.3.1.2. Bargaining power of the buyers
    • 3.3.1.3. Threats of substitution
    • 3.3.1.4. Threats from new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental landscape
    • 3.3.2.5. Legal landscape

Chapter 4. Mammography Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Mammography Market: Product Movement Analysis, 2024 & 2030 (USD Million)
• 4.3. Global Mammography Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Film Screen Systems
  • 4.4.1. Film screen systems market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• 4.5. Digital Systems
  • 4.5.1. Digital systems market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• 4.6. Analog Systems
  • 4.6.1. Analog systems market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• 4.7. 3D Systems
  • 4.7.1. 3D systems market revenue estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. Mammography Market: Technology Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Mammography Market: Technology Movement Analysis, 2024 & 2030 (USD Million)
• 5.3. Global Mammography Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
• 5.4. Breast Tomosynthesis
  • 5.4.1. Breast tomosynthesis market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• 5.5. CAD
  • 5.5.1. CAD market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• 5.6. Digital
  • 5.6.1. Digital market revenue estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. Mammography Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Mammography Market: End Use Movement Analysis, 2024 & 2030 (USD Million)
• 6.3. Global Mammography Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 6.4. Hospitals
  • 6.4.1. Hospitals market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• 6.5. Specialty Clinics
  • 6.5.1. Specialty clinics market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• 6.6. Diagnosis Centers
  • 6.6.1. Diagnosis centers market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• 6.7. Others
  • 6.7.1. Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Mammography Market: Regional Estimates & Trend Analysis by Product, Technology, & End Use

• 7.1. Regional Dashboard
• 7.2. Market Size and Trend Analysis, 2018 to 2030
• 7.3. North America
  • 7.3.1. North America mammography market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.3.2. U.S.
    • 7.3.2.1. Key country dynamics
    • 7.3.2.2. Competitive scenario
    • 7.3.2.3. Regulatory framework
    • 7.3.2.4. Reimbursement scenario
    • 7.3.2.5. U.S. mammography market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.3.3. Canada
    • 7.3.3.1. Key country dynamics
    • 7.3.3.2. Competitive scenario
    • 7.3.3.3. Regulatory framework
    • 7.3.3.4. Reimbursement scenario
    • 7.3.3.5. Canada mammography market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.3.4. Mexico
    • 7.3.4.1. Key country dynamics
    • 7.3.4.2. Competitive scenario
    • 7.3.4.3. Regulatory framework
    • 7.3.4.4. Reimbursement scenario
    • 7.3.4.5. Mexico mammography market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.4. Europe
  • 7.4.1. Europe mammography market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.2. UK
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Competitive scenario
    • 7.4.2.3. Regulatory framework
    • 7.4.2.4. Reimbursement scenario
    • 7.4.2.5. U.K. mammography market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.3. Germany
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Competitive scenario
    • 7.4.3.3. Regulatory framework
    • 7.4.3.4. Reimbursement scenario
    • 7.4.3.5. Germany mammography market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.4. France
    • 7.4.4.1. Key country dynamics
    • 7.4.4.2. Competitive scenario
    • 7.4.4.3. Regulatory framework
    • 7.4.4.4. Reimbursement scenario
    • 7.4.4.5. France mammography market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.5. Italy
    • 7.4.5.1. Key country dynamics
    • 7.4.5.2. Competitive scenario
    • 7.4.5.3. Regulatory framework
    • 7.4.5.4. Reimbursement scenario
    • 7.4.5.5. Italy mammography market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.6. Spain
    • 7.4.6.1. Key country dynamics
    • 7.4.6.2. Competitive scenario
    • 7.4.6.3. Regulatory framework
    • 7.4.6.4. Reimbursement scenario
    • 7.4.6.5. Spain mammography market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.7. Sweden
    • 7.4.7.1. Key country dynamics
    • 7.4.7.2. Competitive scenario
    • 7.4.7.3. Regulatory framework
    • 7.4.7.4. Reimbursement scenario
    • 7.4.7.5. Sweden mammography market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.8. Denmark
    • 7.4.8.1. Key country dynamics
    • 7.4.8.2. Competitive scenario
    • 7.4.8.3. Regulatory framework
    • 7.4.8.4. Reimbursement scenario
    • 7.4.8.5. Denmark mammography market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.9. Norway
    • 7.4.9.1. Key country dynamics
    • 7.4.9.2. Competitive scenario
    • 7.4.9.3. Regulatory framework
    • 7.4.9.4. Reimbursement scenario
    • 7.4.9.5. Norway mammography market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Asia Pacific mammography market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.2. China
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Competitive scenario
    • 7.5.2.3. Regulatory framework
    • 7.5.2.4. Reimbursement scenario
    • 7.5.2.5. China mammography market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. Japan
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Competitive scenario
    • 7.5.3.3. Regulatory framework
    • 7.5.3.4. Reimbursement scenario
    • 7.5.3.5. Japan mammography market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. India
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Competitive scenario
    • 7.5.4.3. Regulatory framework
    • 7.5.4.4. Reimbursement scenario
    • 7.5.4.5. India mammography market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.5. South Korea
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Competitive scenario
    • 7.5.5.3. Regulatory framework
    • 7.5.5.4. Reimbursement scenario
    • 7.5.5.5. South Korea mammography market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.6. Australia
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Competitive scenario
    • 7.5.6.3. Regulatory framework
    • 7.5.6.4. Reimbursement scenario
    • 7.5.6.5. Australia mammography market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.7. Thailand
    • 7.5.7.1. Key country dynamics
    • 7.5.7.2. Competitive scenario
    • 7.5.7.3. Regulatory framework
    • 7.5.7.4. Reimbursement scenario
    • 7.5.7.5. Thailand mammography market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.6. Latin America
  • 7.6.1. Latin America mammography market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6.2. Brazil
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Competitive scenario
    • 7.6.2.3. Regulatory framework
    • 7.6.2.4. Reimbursement scenario
    • 7.6.2.5. Brazil mammography market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. Argentina
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Competitive scenario
    • 7.6.3.3. Regulatory framework
    • 7.6.3.4. Reimbursement scenario
    • 7.6.3.5. Argentina mammography market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.7. Middle East & Africa
  • 7.7.1. Middle East & Africa mammography market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.7.2. Saudi Arabia
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Competitive scenario
    • 7.7.2.3. Regulatory framework
    • 7.7.2.4. Reimbursement scenario
    • 7.7.2.5. Saudi Arabia mammography market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.7.3. UAE
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Competitive scenario
    • 7.7.3.3. Regulatory framework
    • 7.7.3.4. Reimbursement scenario
    • 7.7.3.5. UAE mammography market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.7.4. South Africa
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Competitive scenario
    • 7.7.4.3. Regulatory framework
    • 7.7.4.4. Reimbursement scenario
    • 7.7.4.5. South Africa mammography market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.7.5. Kuwait
    • 7.7.5.1. Key country dynamics
    • 7.7.5.2. Competitive scenario
    • 7.7.5.3. Regulatory framework
    • 7.7.5.4. Reimbursement scenario
    • 7.7.5.5. Kuwait mammography market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis by Key Market Participants
• 8.2. Company Categorization
• 8.3. Company Market Share Analysis
• 8.4. Company Heat Map Analysis
• 8.5. Strategy Mapping
  • 8.5.1. Expansion
  • 8.5.2. Mergers & Acquisition
  • 8.5.3. Partnerships & Collaborations
  • 8.5.4. New Product Launches
  • 8.5.5. Research And Development
  • 8.5.6. Company Profiles
  • 8.5.7. Hologic Inc.
    • 8.5.7.1. Company overview
    • 8.5.7.2. Financial performance
    • 8.5.7.3. Product Benchmarking
    • 8.5.7.4. Strategic initiatives
  • 8.5.8. Analogic Corporation
    • 8.5.8.1. Company overview
    • 8.5.8.2. Financial performance
    • 8.5.8.3. Product Benchmarking
    • 8.5.8.4. Strategic initiatives
  • 8.5.9. Canon Medical Systems Corporation
    • 8.5.9.1. Company overview
    • 8.5.9.2. Financial performance
    • 8.5.9.3. Product Benchmarking
    • 8.5.9.4. Strategic initiatives
  • 8.5.10. Fujifilm Corporation
    • 8.5.10.1. Company overview
    • 8.5.10.2. Financial performance
    • 8.5.10.3. Product Benchmarking
    • 8.5.10.4. Strategic initiatives
  • 8.5.11. Siemens Healthcare
    • 8.5.11.1. Company overview
    • 8.5.11.2. Financial performance
    • 8.5.11.3. Product Benchmarking
    • 8.5.11.4. Strategic initiatives
  • 8.5.12. Toshiba Medical Systems
    • 8.5.12.1. Company overview
    • 8.5.12.2. Financial performance
    • 8.5.12.3. Product Benchmarking
    • 8.5.12.4. Strategic initiatives
  • 8.5.13. GE Healthcare
    • 8.5.13.1. Company overview
    • 8.5.13.2. Financial performance
    • 8.5.13.3. Product Benchmarking
    • 8.5.13.4. Strategic initiatives
  • 8.5.14. Metaltronica
    • 8.5.14.1. Company overview
    • 8.5.14.2. Financial performance
    • 8.5.14.3. Product Benchmarking
    • 8.5.14.4. Strategic initiatives
  • 8.5.15. Koninklijke Philips NV
    • 8.5.15.1. Company overview
    • 8.5.15.2. Financial performance
    • 8.5.15.3. Product Benchmarking
    • 8.5.15.4. Strategic initiatives
  • 8.5.16. PLANMED OY
    • 8.5.16.1. Company overview
    • 8.5.16.2. Financial performance
    • 8.5.16.3. Product Benchmarking
    • 8.5.16.4. Strategic initiatives

관련자료